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Rectal carcinomaAbstract Background: Rectal cancer is one of the most common tumors in industrialized coun-
tries and one of the most common malignant tumors of the gastrointestinal tract. MR imaging
has become the most accurate technique in local staging of rectal cancer; this is due to advances
in terms of imaging equipment, coils, and sequences that have progressively improved the tech-
nique, with a parallel increase in accuracy.
Objective: To assess the role of magnetic resonance imaging with diffusion in staging of rectal car-
cinoma before and after chemo and radiation therapy in relation to histopathological ﬁndings.
Materials and methods: The studied group included 19 patients proved to be rectal carcinoma by
colonoscopy between October 2011 and December 2013. All patients were evaluated with conven-
tional MRI and diffusion weighted images. Our population which was staged as Tx N2 M0 and T3–
T4 Nx M0 stage, underwent MR and diffusion weighted imaging (DWI) before neoadjuvant chemo
and radiation therapy and later 6–8 wks. After the end of the treatment they performed again MR
for the re-staging of disease. The sensitivity, speciﬁcity and diagnostic accuracy for both examina-
tions were calculated. Our gold standard was the histopathology.
Results: For T stage conventional MRI showed 60% sensitivity and 33% speciﬁcity with overall
diagnostic accuracy 46.5% which increased after adding DWI to 87% sensitivity and 80% speci-
ﬁcity with an overall accuracy 83.5%. N stage prediction by conventional MRI was 74% sensitivity
and 80% speciﬁcity with an overall accuracy 78%. This increased after adding DWI to 83%
sensitivity and 83% speciﬁcity with an overall accuracy 83%. MRI with DWI showed diagnostic
accuracy 94.7%, and without DWI the diagnostic accuracy was 84.2%.
Conclusion: The use of additional DWI yields better diagnostic accuracy than does use of conven-
tional MR imaging alone in the evaluation of complete response to neoadjuvant chemo radiother-
apy in patients with locally advanced rectal cancer.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1 TNM guidelines for the staging of rectal cancer
(Kaur et al. (3)).
Descriptor Deﬁnition
Tumor
Tx Determination of tumor extent is not possible because
of incomplete information
Tis Tumor in situ involves only the mucosa and has not
grown beyond the muscularis mucosa (inner muscle
layer)
T1 Tumor grows through the muscularis mucosa and
extends into the submucosa
T2 Tumor grows through the submucosa and extends
into the muscularis propria
T3 Tumor grows through the muscularis propria and into
the mesorectum
T3a Tumor extends < 5 mm beyond the muscularis
propria
T3b Tumor extends 5–10 mm beyond the muscularis
propria
T3c Tumor extends > 10 mm beyond the muscularis
propria
T4a Tumor penetrates the visceral peritoneum
T4b Tumor directly invades or is adherent to other organs
or structures
Node
Nx Nodal staging is not possible because of incomplete
information
N0 No cancer in regional lymph nodes
N1a Tumor in one regional lymph node
N1b Tumor in two or three regional nodes
N1c Tumor deposits in the subserosa, mesentery, or
nonperitonealized pericolic or perirectal tissues
without regional nodal metastasis
N2a Tumor in four to six regional nodes
N2b Tumor in seven or more regional nodes
Metastases
M0 No distant spread
M1a Tumor is conﬁned to one distant organ or site (eg,
liver, lung, ovary, non-regional node)
M1b Tumor spread to more than one organ or site or the
peritoneum
Stage
0 Tis, N0, M0
I T1–T2, N0, M0
IIA T3, N0, M0
IIB T4a, N0, M0
IIC T4b, N0, M0
IIIA T1–T2, N1, M0; T1, N2a, M0
IIIB T3–T4a, N1, M0; T2–T3, N2a, M0; T1–T2, N2b, M0
IIIC T4a, N2a, M0; T3–T4a, N2b, M0; T4b, N1–N2, M0
IVA Any T, any N, M1a
IVB Any T, any N, M1b
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Magnetic resonance (MR) imaging is the most promising tech-
nique for the local staging of rectal cancer (1). Diffusion-
weighted MRI (DWMRI) is becoming increasingly important
in the assessment of malignant tumors.
In patients with rectal cancer who have received concurrent
chemotherapy and radiation therapy (CCRT) before surgery,
conventional magnetic resonance (MR) imaging has low accu-
racy in prediction of the pathologic stage owing to over staging
or under staging.
The factors related to this problem include ﬁbrosis, desmo-
plastic reaction, edema, inﬂammation, and viable tumor nets
at a ﬁbrotic scar from a previous tumor (2).
The aim of this study was to assess the role of magnetic
resonance with diffusion in diagnosis, staging of rectal carci-
noma in relation to histopathological ﬁndings.
2. Materials and methods
2.1. Subjects
The study was done in Ain Shams University Hospital and
specialized private center in Cairo during the period from
October 2011 till December 2013. Nineteen patients proved
to be rectal carcinoma by colonoscopy were included in this
study. Our population was staged as Tx N2 M0 (Table 1)
and T3–T4 Nx M0, which underwent preoperative MR with
and without diffusion before neoadjuvant chemo and radia-
tion therapy. After the end of the treatment by 6–8 wks, they
performed again MR for the re-staging of disease.
2.2. Acquisition and processing of MRI with and without
diffusion
The study was performed with a 1.5-T MR system (Achieva;
Philips Medical Systems, Best, The Netherlands). The exami-
nation was performed with phased-array surface coils. The
patient is positioned supine. In some cases we used intrarectal
gel for expanding the rectum and better delineation of the
tumor. In other patients rectal enema was performed and in
the rest of patients neither was used due to patients refusal.
The phased-array surface coil is placed on the pelvis.
2.2.1. Scanning protocol
Localizer images in three orthogonal planes were taken ﬁrst,
then Sagittal, T2-weighted, fast (turbo) spin-echo sequence
from one pelvic sidewall to the other (Sequence parameters
TR 3500 ms TE 120 FOV= AP 270 RL 158 mm, voxel size
RL 1.2 mm AP1.5 slice thickness 6 mm slice orientation
sagittal).
Axial sections of the whole pelvis with large ﬁeld of view T1
weighted images and T2 weighted images (T2 weighted images
sequence parameters: TR 5500 ms TE 115 FOV = AP 270 RL
350 mm, slice thickness 6 mm, transverse slice orientation; T1
weighted images sequence parameters: TR 550 ms TE 24
FOV= AP 270 RL 350 mm, voxel size RL 1.2 mm AP1.5,
slice thickness 6 mm, transverse slice orientation).
Magniﬁed views with T2-weighted high resolution thin-
section axial oblique images through the rectal cancer andadjacent tissues. This sequence was performed perpendicular
to the long axis of the rectum and at the level of the tumor
(Sequence parameter: TR 3500 ms TE 120 FOV= 270 TO
320 mm, voxel size RL 1.2 mm AP1.5, NSA 2 slice thickness
3 mm, axial oblique slice orientation).
A high-spatial-resolution coronal oblique T2 weighted
imaging for patients with low rectal cancers (Sequence parame-
ters: TR 3500 ms TE 120 FOV= 270 TO 320 mm, voxel size
RL 1.2 mm AP1.5 slice thickness 3 mm).
The diffusion weighted imaging ‘‘DWI’’: Axial DWI with
single shot echo planar imaging (EPI) was performed at b
Value of diffusion-weighted MR imaging 555values of 0, 500 and 1000 s/mm2. Postcontrast sequences (axial
oblique, coronal oblique, sagittal oblique all parallel to the
direction of the rectum).
2.3. Image analysis
MRI with DWI was done before and after neoadjuvant ther-
apy with interval 6–8 wks where we assess the signal intensity
change in T2 weighted images and postcontrast images then we
add diffusion weighted images to assess viable tumoral tissue
qualitatively then quantitatively by measuring the attenuation
diffusion coefﬁcient (ADC) values and comparing it with the
pretherapeutic study using 1.2 · 103 mm2/sec as cutoff value
to differentiate viable tissue from ﬁbrosis within the mass
and the LNs then restaging again and correlation of the result
with the histopathological result.
2.4. ADC calculation
The mean ADC of the rectal mass was calculated by position-
ing multiple regions of interest (ROIs) over the tumor in
consecutive image sections and then the mean ADC was calcu-
lated. We calculated the ADC value for each lymph node (LN)
by placing the region of interest ‘‘ROI’’ well in the conﬁnes of
the LN.
2.5. Statistical analysis
Statistical analysis was done using MedCalc version 12.5
(MedCalc Software bvba, Ostend, Belgium) and DAG stat
(Mackinnon, 2000). The paired t test was used to compare
paired numerical data. To determine the diagnostic value of
conventional MRI with and without DWI, series of 2 · 2
contingency tables were constructed to contrast the study of
interest to the histopathological result. The following measures
were then calculated: sensitivity, speciﬁcity, and overall
diagnostic accuracy.
3. Results
Our study included 19 patients proved to be rectal carcinoma
by colonoscopy ranging in age from 25 to 84 years old with the
mean age 51.7 (11 males, 8 females). These cases presented pri-
marily with bleeding per rectum. Our patients included 5
patients staged according to MRI as T4 and 14 staged as T3.
These patients received adjuvant therapy for 6–8 weeks then
restaging MRI was done. Using conventional MRI without
DWI there was complete response in one patient, 10 staged
as T2 and 8 staged as T3. When correlated with histopatho-
logical results the patient staged by MRI as T0 (complete
response) was accurately staged, and 3 patients were accurately
staged as T2 and 6 patients were accurately staged as T3.
This gives only one true negative and 9 true positive results
giving 60% sensitivity and 33% speciﬁcity with an overall
diagnostic accuracy 46.5%.
After adding DWI there was complete response in 4
patients (Fig. 1), 7 staged as T2 (Figs. 2 and 3) and 8 staged
as T3. When correlated with histopathological results, 4
patients staged as T0 (complete response) were accurately
staged, and 4 patients were accurately staged as T2 and 7patients were accurately staged as T3 (see Tables 2–5).
Table 2 shows correlation of the T stage after the adjuvant
therapy with the pathological results using conventional
MRI without DWI.
This gives 4 true negative and 11 true positive results giving
79% sensitivity and speciﬁcity 80% with an overall accuracy
79.5%. So the use of additional DWI yields better diagnostic
accuracy than does use of conventional MR imaging alone
in the evaluation of complete response to neoadjuvant
chemoradiotherapy in patients with locally advanced rectal
cancer.
As regards the nodal staging after chemoradiotherapy, by
conventional MRI without diffusion 32 LNs were detected,
13 suggested to be benign and 19 suggested to be malignant.
Among the 19 LNs suggested to be malignant by conven-
tional MRI without diffusion, 2 LNs proved to be benign by
histopathological evaluation (false positive), while among the
13 LNs diagnosed by MRI to be benign, 5 proved to be malig-
nant by histopathological evaluation (false negative) with 6
LNs not detected at all by conventional MRI. This gives
74% sensitivity and 80% speciﬁcity with an overall accuracy
78%.
After adding the DWI and evaluation of ADC, 36 LNs
were detected, 14 suggested to be benign and 22 suggested to
be malignant.
Among the 22 LNs suggested to be malignant by DWI, 2
were proved to be benign by histopathological evaluation
(false positive), while among the 14 LNs suggested to be
benign by DWI, 4 LNs proved to be malignant by histopatho-
logical evaluation (false negative), with 2 LNs not detected at
all by MRI with DWI. This gives 83% sensitivity and 83%
speciﬁcity with an overall accuracy 83%.
There were no much increase in the diagnostic accuracy but
there was increase in the detected LN as it highlights the LN
but still there is difﬁculty in differentiating benign and malig-
nant nodes.
4. Discussion
Rectal cancer is one of the most common tumors in indus-
trialized countries and one of the most common malignant
tumors of the gastrointestinal tract (3). During the past decade
magnetic resonance imaging (MRI) has been proven to be the
most accurate staging modality for primary rectal cancer (4).
With preoperative imaging the T-stage, nodal involvement,
and location of the tumor are evaluated, which determine
the type of preoperative treatment. So far, MRI has not been
able to accurately predict T-stage unless an endorectal coil is
used (5). However, an endoluminal technique leads to less visi-
bility of surrounding structures in the mesorectum because of
the limited ﬁeld of view. Endorectal MRI has good accuracy
for identiﬁcation of T1 tumors, and is therefore the examina-
tion of choice for staging superﬁcial rectal cancer (6).
However, it is less accurate for staging of the more advanced
tumors. Therefore MRI with phased-array coils is widely
adopted as the most accurate technique for staging of these
bulky T3 and T4 tumors (7).
DWI is becoming increasingly important in the assessment
of malignant tumors. It is generally accepted that DWI enables
noninvasive characterization of biologic tissues on the basis of
their water diffusion properties (8). In our study we evaluate
Fig. 1a–d 1st pre adjuvant therapy conventional MRI: (a) axial oblique T2 FSE image shows uneven mural thickening at the upper
rectum involving the mucosa and submucosa and focally invading the mesorectal fat. (b) Coronal oblique T2 FSE image shows the extent
of rectal mass with no involvement of levator ms or anal sphincter complex. (c) Sagittal T2WI shows the distance to anal verge. (d) Axial
oblique T1 postcontrast with fat suppression shows heterogeneously enhancing mass with left internal iliac LN with irregular border and
heterogeneously enhancing as the rectal mass.
Fig. 1e–f Diffusion weighted imaging ﬁndings: (e) inversed diffusion weighted images, (f) the corresponding ADC map, both show that
the mass and the regional LN show considerable degree of diffusion restriction on the corresponding area on the map giving low ADC
values with mean ADC for the mass of 0.6 · 103 mm2/sec, while for the left internal iliac LN of 0.7 · 103 mm2/sec keeping with
malignant nature. Staging according to MRI criteria: The case was staged as T3bN1.
Fig. 1g–i 2nd stage MRI after adjuvant therapy: (g) axial oblique T2 FSE image, (h) T1-post-contrast fat suppression, and both show
disappearance of the mural thickening. (i) Inversed diffusion weighted images at the level of previous rectal mass and LN show
disappearance of the tiny perirectal LNs and left internal iliac LN. Restaging according to MRI criteria: Restaging after adjuvant therapy
is suggested to be T0N0. Pathologically proved that there is good response with T0N1 stage (this is due to microscopic inﬁltration for tiny
perirectal LN).
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Fig. 2a–c 1st pre adjuvant therapy conventional MRI: (a) axial oblique T2 FSE image shows localized mural thickening at the
midrectum with perilesional lymph node. (b) Axial oblique T2 FSE image at different level shows right sided perilesional LN. (c) Axial
oblique T1 postcontrast with fat suppression shows heterogeneously enhancing mass with perimural haziness despite distension of the
rectum, right perirectal LN with irregular border and heterogeneously enhancing as the rectal mass.
Fig. 2d–e Diffusion weighted imaging ﬁndings: (d) inversed DW images at different levels. The mass and the perirectal LN, both images
show considerable degree of diffusion restriction. (e) The corresponding ADC map giving low ADC value with the mean ADC for the
mass of 1 · 103 mm2/sec while the LNs ranging between 0.6 and 0.9 · 103 mm2/sec keeping with malignant nature. Staging according to
MRI criteria: The case is suggested to be staged as T3aN1.
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rectal tumors as regards evaluation of the tumor response to
chemoradiotherapy (CRT) and nodal restaging. Locally
advanced rectal cancer has a poor prognosis because of
the high frequency of metastasis and local recurrence.
Concurrent chemoradiotherapy (CCRT) is performed in rectal
cancer patients in whom the circumferential resection margin
(CRM) or anal sphincter is threatened or involved, as identi-
ﬁed at preoperative high-resolution pelvic MR imaging (9).
After CCRT, the tumor response is classiﬁed as complete
response (no residual tumor), partial response (tumor volume
decreased > 50% or down staging), or no response after post-
operative pathologic analysis of the tumor specimens. In our
study the restaging using DWI with the calculation of ADC
values gives 87% sensitivity and speciﬁcity 80% with overall
accuracy 83.5% while using conventional MRI without DWI
gives 60% sensitivity and speciﬁcity 33% with overall accuracy
46.5%. Few prior MR imaging studies have been conducted to
assess the effect of long-course neoadjuvant CRT on themorphologic features of primary rectal cancer depending only
on the change in T2 signal intensity without adding Diffusion
weighted images. Similar studies reported that in restaging of
irradiated rectal cancer, MR imaging had an accuracy of
52% for T stage (10). Another studies reported similar rates
of MR imaging accuracy for T stage after CRT was 47%
(11). The majority of the inaccuracies in both series were in
over staging disease. This gives similar result to our study
when evaluating T stage depending on morphological features
using T2 weighted images with the inaccuracy in the over stag-
ing at T2 stage due to inability to differentiate ﬁbrosis from
tiny residual tumors tissue within the desmoplastic reaction
induced by neoadjuvant therapy and also in the inability to
diagnose complete response from residual tumoral tissues.
Although MRI is considered the most accurate tool for pri-
mary tumor staging in rectal cancer, yet, this modality has
intrinsic limitations in the differentiation of residual viable
tumor from surrounding ﬁbrosis after neoadjuvant CRT of
rectal cancer. The ﬁbrous tissue present after treatment causes
Fig. 2f–i 2nd stage MRI after adjuvant therapy: (f) axial oblique T2 FSE image, (g) sagittal T1-post-contrast fat suppression, both show
disappearance of the mass with hypo intense diffuse wall thickening with no residual mass. (h) Inversed diffusion weighted images at the
level of previous rectal mass, (i) ADC at the same level, both show disappearance of the tiny perirectal LNs with thin rim of diffusion
restriction within the mural conﬁnes with low ADC values denoting favorable response to therapy yet with residual tumoral tissue within
the conﬁnes of the wall. Restaging according to MRI criteria: Restaging after adjuvant therapy was T2N0. Pathologically proved that
there is good response with T2N0 stage (adding DWI differentiates residual tissue from post therapeutic ﬁbrosis).
Fig. 3a–d 1st pre adjuvant therapy conventional MRI: (a and b) sagittal T2 FSE shows large fungating mass along the proximal 1/3 of
the rectum and rectosigmoid junction, and this tumoral tissue shows focal external extramural extension, (b) the mass abuts the uterus
superiorly. (c and d) Axial oblique T2 FSE images, (c) show left internal iliac LN with irregular border although not enlarged yet harbor
the same signal as the rectal mass, (d) show also tiny suspicious presacral LN.
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Fig. 3g–j 2nd stage MRI after adjuvant therapy: (g) sagittal T2 FSE, (h) axial oblique T2 FSE, both show that the mural thickening
becomes diffuse with perirectal stranding. (i) Inversed diffusion WI, (j) corresponding ADC map both show only area of diffusion
restriction which conﬁnes to the wall with reduction of its ADC to 1.6 · 103 mm2/sec, disappearance of the perirectal LN and left internal
iliac LN. Restaging according to MRI criteria: Restaging after adjuvant therapy was suggested to be T2N0. This case pathologically
proved to have partial response with pathological stage T3aN0 stage (under staging owing to difﬁculty in differentiation between the
desmoplastic reaction and tumoral inﬁltration at stage T3a).
Fig. 3e–f Diffusion weighted imaging ﬁndings: (e) inversed DW images at different levels. The mass and the perirectal LN show
considerable degree of diffusion restriction, (f) the corresponding ADC map giving low ADC value with mean ADC for the mass
1 · 103 mm2/sec while the LNs ranging between 0.9 and 1 · 103 mm2/sec keeping with malignant nature. Staging according to MRI
criteria: The case was suggested to be staged as T4aN1.
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Table 2 Shows correlation of the T stage after the adjuvant
therapy with the pathological results using conventional MRI
without DWI.
T stage by MRI without DWI after CRT Pathological stage
T0 T2 T3
T0 1 1 0 0
T2 10 4 3 3
T3 8 0 2 6
Total (cases) 19 5 5 9
Table 3 Shows correlation of the T stage after the adjuvant
therapy with the pathological results using conventional MRI
with DWI.
T stage by MRI with DWI after CRT Pathological stage
T0 T2 T3
T0 4 4 0 0
T2 7 1 4 2
T3 8 0 1 7
Total (cases) 19 5 5 9
Table 4 Comparison between rectal MRI without DWI as
regards nodal staging versus histopathology.
N stage by MRI without DWI Pathological stage
Benign Malignant
Benign LN 13 8 5
Malignant LN 19 2 17
Table 5 Comparison between rectal MRI with DWI as
regards nodal staging versus histopathology.
N stage by MRI with DWI Pathological stage
Benign Malignant
Benign LN 14 10 4
Malignant LN 22 2 20
560 R.A. Marouf et al.thickening of the rectal wall. Thus, MR imaging cannot readily
differentiate T0 or T1 stage tumors from T2 stage tumors
because it is not possible to visualize individual rectal wall
layer (12). DWI has been shown to have several potential bene-
ﬁts for the assessment of tumor localization and staging (13).
The ADC values obtained from DWI measurements reﬂect
tumor cellularity and anti-tumor treatment decreases tumor
cellularity, so CRT should increase the ADC value.
Increased ADC values have also been correlated with tumor
necrosis and reduced cell density (14), and most studies (15–
17) have found an increase in ADC after CRT. Kim et al.
(15) showed that neoadjuvant CRT caused a signiﬁcant
increase in the ADC values of 76 rectal cancer patients andCai et al. (16) showed that the tumor ADC values changed
during the course of neoadjuvant chemo radiation as the
ADC value at the 2nd week of therapy was signiﬁcantly corre-
lated with the tumor response. Our study showed similar
results to these studies as there is signiﬁcant increase in the
ADC values before and after CRT with the mean ADC values
prior to treatment were 0.7 after treatments 1.5 using 1.2 as
cutoff values to discriminate residual tumor from ﬁbrosis.
Only a few studies have been performed to evaluate the added
value of DWI in determining a complete response (CR) to
neoadjuvant CRT. However, several authors have advocated
the use of DWI as a tumor response monitoring tool. Also
Kim et al. (15) concluded that DWI can be used to distinguish
favorable responders from poor responders to neoadjuvant
CRT with the mean ADC of the CR group was signiﬁcantly
higher than that of the non-CR group. They reported that add-
ing DWI to T2-weighted imaging gave diagnostic accuracy
range of 82–85% and was more helpful for detecting viable
tumors after neoadjuvant CRT than T2-weighted imaging
alone (accuracy 70%) in patients with locally advanced rectal
cancer. Our study gave similar results as when adding DWI,
there was signiﬁcant increase in the diagnostic accuracy espe-
cially the speciﬁcity giving also high negative predictive value
as we were able to differentiate between complete responder
and non-responder. Song et al. (13) evaluated the added value
of diffusion-weighted imaging (DWI) in combination with T2
weighted imaging (T2WI) compared with T2WI alone or posi-
tron emission tomography (PET)/CT for detecting viable
tumor after neoadjuvant chemo radiation therapy (CRT) in
patients with locally advanced rectal cancer. Their results were
that in detecting viable tumors, DWI with T2WI improved
diagnostic accuracies (90%) over T2WI alone (76%). The
sensitivity of DWI with T2WI was signiﬁcantly higher than
those of T2WI alone. Their results showed agreement with
our results regarding the increased overall accuracy using
DWI + T2WI although the relatively high value using T2
alone at the study of Song et al. could be attributed to the
higher ﬁeld strength (3 tesla) with better spatial and temporal
resolution at T2WI. It is difﬁcult to differentiate a metastatic
lymph node and irradiated lymph node change with post-
CCRT MR imaging by using morphologic criteria. In particu-
lar, a change in a lymph node with or without metastasis after
CCRT is assumed to be associated with metastasis, resulting in
lymph node over staging (15). It is known that irradiated
malignant nodes often become partly necrotic resulting in
higher ADCs (17). Also Lambregts et al. (17) found that the
main role of DWI for lymph node evaluation was that it
improved the number of detected nodes, because nodes were
more easily detected on DWI due to their high signal intensity
compared with the suppressed background signal of surround-
ing tissues; as lymph nodes have a high cellular density, they
generally show restricted diffusion and are easily detected on
DWI. Our study comes in agreement with their study as
regards the increased detection rate of the involved LN where
by conventional MRI only 19 LNs were detected after the add-
ing DWI 36LNs were detected. In conclusion the diagnostic
accuracy in the evaluation of chemo radiotherapy and tumor
response in case of locally advanced rectal tumors signiﬁcantly
increased when DWI was added to conventional MR imaging.
So DWI has a growing role in rectal cancer staging and eval-
uating the post chemo radiotherapy state.
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